Crinetics Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
Crinetics Pharmaceuticals, Inc. (CRNX) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of $3.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2026-02-26
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2025 was $3.97M, a 12.83% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2024 was $3.52M, a 30.62% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2023 was $2.69M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|
| 2025-12-31 | $3.97M 10-K · filed 2026-02-26 |
| 2024-12-31 | $3.52M 10-K · filed 2026-02-26 |
| 2023-12-31 | $2.69M 10-K · filed 2026-02-26 |